---
figid: PMC3681479__oncotarget-03-1483-g001
figtitle: Promise of dual targeting Akt/mTOR signaling in lethal prostate cancer
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC3681479
filename: oncotarget-03-1483-g001.jpg
figlink: /pmc/articles/PMC3681479/figure/F1/
number: F1
caption: Loss of function of PTEN leads to activation of the mTOR pathway mainly via
  the PI3K/Akt pathway and secondarily via the MEK pathway. Inhibition of mTOR using
  MK-8669 leads to a feedback loop activation of Akt (1) Our findings suggest that
  inhibition of Akt using MK-2206 is not effective for inhibition of mTOR because
  of MEK pathway activation (2). Dual inhibition of both with MK-8669 and MK-2206
  leads to effective inhibition of Akt/mTOR signaling.
papertitle: The promise of dual targeting Akt/mTOR signaling in lethal prostate cancer.
reftext: Nicolas Floc'h, et al. Oncotarget. 2012 Dec;3(12):1483-1484.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.948409
figid_alias: PMC3681479__F1
figtype: Figure
redirect_from: /figures/PMC3681479__F1
ndex: 5a381581-def5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3681479__oncotarget-03-1483-g001.html
  '@type': Dataset
  description: Loss of function of PTEN leads to activation of the mTOR pathway mainly
    via the PI3K/Akt pathway and secondarily via the MEK pathway. Inhibition of mTOR
    using MK-8669 leads to a feedback loop activation of Akt (1) Our findings suggest
    that inhibition of Akt using MK-2206 is not effective for inhibition of mTOR because
    of MEK pathway activation (2). Dual inhibition of both with MK-8669 and MK-2206
    leads to effective inhibition of Akt/mTOR signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pik3r1
  - Pdk1
  - Pdpk1
  - ras
  - Hras
  - Kras
  - Rem1
  - Re
  - Zhx2
  - Mdk
  - Akt1
  - Ephb2
  - Mapk1
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PDK1
  - PDPK1
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - EPHB2
  - MAPK1
  - MAPK3
  - RPTOR
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Ras64B
  - Ras85D
  - den
  - Raf
  - Dsor1
  - Mtk
  - Akt
  - Erk7
  - rl
  - Crtc
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
